Outbrain (NASDAQ:OB) reported quarterly earnings of $0.28 per share. This is a 275 percent increase over losses of $(0.16) per share from the same period last year. The company reported $247.00 million in sales this
Cowen has raised Impel NeuroPharma Inc's (NASDAQ: IMPL) price target to $55 from $35, with an Outperform rating, after the FDA approved Trudhesa for the acute treatment of migraine.
The analyst sees more than 100% upside for the stock.
According to data shared on Blockchain.com, a cryptocurrency whale has moved crypto from a wallet that had accumulated over 74,105 Bitcoin (CRYPTO: BTC) wo